IP Library Granted Patent US 7,115,368
Granted Patent B2
US 7,115,368 · App. 10/041,030 · Granted Oct 3, 2006

Diagnosis and treatment of cancer using mammalian pellino polypeptides and polynucleotides

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,115,368
App. No.
10/041,030
Granted
Oct 3, 2006
Kind
B2
Abstract

The present invention provides methods, reagents, and kits for diagnosing and treating cancer in a mammal, e.g., a human. This invention is based upon the discovery that Pellino 1 or 2 is overexpressed and/or amplified in cancer. Methods to detect cancer or a propensity to develop cancer, to monitor the efficacy of a cancer treatment, and to treat cancer, by inhibiting the expression and/or activity of Pellino 1 or 2 in a cancer cell are included.

Claims (8)

1. A method of detecting epithelial cancer cells in a biological sample from a mammal, the method comprising the steps of:

(a) providing the biological sample from the mammal; and

(b) detecting an increase in copy number of a gene encoding SEQ ID NO:4 in the biological sample compared to control, thereby detecting the presence of epithelial cancer cells in the biological sample.

2. The method of claim 1 , wherein the detecting step further comprises:

(i) contacting the gene with a probe specific for the gene under conditions in which the probe selectively hybridizes to the gene to form a stable hybridization complex; and

(ii) detecting the hybridization complex.

3. The method of claim 1 , wherein the epithelial cancer is a lung, colon, or ovarian cancer.

4. The method of claim 1 , wherein the mammal is a human.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 18, 2005
From: AMGEN SF, LLC
To: AMGEN INC.
Reel/Frame 016871/0736 →
MERGER Recorded Jun 7, 2005
From: TULARIK INC.
To: ARROW ACQUISITION, LLC
Reel/Frame 016309/0003 →
CHANGE OF NAME Recorded Jun 7, 2005
From: ARROW ACQUISITION, LLC
To: AMGEN SF, LLC
Reel/Frame 016309/0812 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 22, 2002
From: POWERS, SCOTT; MU, DAVID; XIANG, PHIL; PENG, YUE
To: TULARIK INC.
Reel/Frame 012853/0759 →